University of New Mexico Clinical and Translational Science Center (CTSC) Market Research Report

Background

Overview

The University of New Mexico Clinical and Translational Science Center (CTSC) is a pivotal institution dedicated to advancing clinical and translational research. As a member of the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) Consortium, the CTSC plays a crucial role in transforming scientific discoveries into tangible health improvements. The center's mission is to support high-quality collaborative translational science locally, regionally, and nationally, fostering scientific and operational innovation to enhance the efficiency and effectiveness of clinical translational research. Additionally, the CTSC is committed to creating, providing, and disseminating domain-specific translational science training and workforce development.

Mission and Vision

• Mission: To support high-quality collaborative translational science locally, regionally, and nationally; foster scientific and operational innovation to improve the efficiency and effectiveness of clinical translational research; and create, provide, and disseminate domain-specific translational science training and workforce development.

• Vision: To catalyze scientific discovery into improved health by enabling high-quality clinical and translational research (CTR)—locally, regionally, and nationally.

Primary Area of Focus

The CTSC focuses on accelerating the translation of biomedical discoveries into clinical applications, thereby improving human health. This involves streamlining the path from laboratory research to clinical practice and community health through clinical studies.

Industry Significance

As part of the NIH CTSA Consortium, the CTSC contributes to a national network of institutions dedicated to advancing clinical and translational research. This collaboration enhances the capacity to translate scientific discoveries into improved health outcomes, addressing public health challenges and fostering innovation in medical research.

Key Strategic Focus

Core Objectives

• Accelerating Translational Research: Facilitating the movement of scientific discoveries from the laboratory to clinical applications and community health improvements.

• Enhancing Research Efficiency: Streamlining processes to improve the effectiveness of clinical translational research.

• Workforce Development: Providing training and development opportunities to build a skilled workforce in translational science.

Specific Areas of Specialization

• Clinical Research Coordination: Offering comprehensive support for the design and execution of clinical studies.

• Participant Recruitment: Implementing strategies to engage diverse populations in clinical research.

• Biomedical Informatics: Utilizing data science to enhance medical knowledge and clinical outcomes.

Key Technologies Utilized

• Clinical Research Unit: Equipped with state-of-the-art facilities to support various clinical research activities.

• Biomedical Informatics Tools: Employing advanced data analytics platforms to manage and analyze research data.

• Translational Laboratory: Providing cutting-edge equipment and technical assistance for laboratory techniques.

Primary Markets or Conditions Targeted

• Chronic Diseases: Addressing conditions such as diabetes, obesity, and addiction prevalent in New Mexico.

• Rural Health: Focusing on health disparities in rural communities through targeted research and interventions.

• Community Health: Engaging with local communities to improve health outcomes through collaborative research.

Financials and Funding

Funding History

The CTSC has received substantial funding from the NIH, including a five-year, $23 million grant renewal in 2015, recognizing its success in conducting innovative biomedical research.

Recent Funding Rounds

In April 2025, the CTSC was awarded $2 million by the NIH to pilot the Primary Care – Building Research Integration in Diverse Geographic Environments (PC-BRIDGE) initiative. This one-year pilot program aims to involve new communities in clinical research, particularly in rural areas, and implement innovative study designs to address common health issues in primary care.

Notable Investors

The primary funding source for the CTSC is the National Institutes of Health (NIH), which supports its mission through various grants and awards.

Intended Utilization of Capital

The funds are utilized to support clinical and translational research initiatives, enhance research infrastructure, develop workforce training programs, and engage with community health projects to improve health outcomes in New Mexico and beyond.

Pipeline Development

Key Pipeline Candidates

The CTSC supports a diverse portfolio of research projects targeting various health conditions, including chronic diseases like diabetes, obesity, and addiction. Specific pipeline candidates are not publicly disclosed.

Stages of Clinical Trials or Product Development

The CTSC facilitates clinical trials at various stages, from early-phase studies to more advanced trials, depending on the specific research project.

Target Conditions

• Diabetes: Investigating new treatments and interventions.

• Obesity: Developing strategies for prevention and management.

• Addiction: Exploring therapeutic approaches for substance use disorders.

Relevant Timelines for Anticipated Milestones

Specific timelines for research milestones are project-dependent and are managed by the respective research teams within the CTSC.

Technological Platform and Innovation

Proprietary Technologies

• Clinical Research Unit: A fully equipped facility supporting various clinical research activities.

• Biomedical Informatics Tools: Advanced data analytics platforms for managing and analyzing research data.

• Translational Laboratory: State-of-the-art equipment and technical assistance for laboratory techniques.

Significant Scientific Methods

• Long-Read Nucleic Sequencing: A novel technique developed in the CTSC Translational Laboratory for detecting ribonucleic acids.

• Data Analytics Platforms: Utilizing platforms like TriNetX to simplify analytics and accelerate time to insight.

Leadership Team

Key Executive Profiles

• Dr. Nancy Pandhi, MD, PhD, MPH: Director of the CTSC and Professor of Family & Community Medicine. Dr. Pandhi leads the CTSC's strategic direction and oversees its research initiatives.

• Dr. Hengameh Raissy, PharmD: Professor of Pediatrics and Vice President for Research, Health Sciences. Dr. Raissy plays a pivotal role in advancing research initiatives within the CTSC.

• Dr. Christos Argyropoulos, MD, MS, PhD, FASN: Clinical and Translational Researcher and Head of the Nephrology Division at UNM. Dr. Argyropoulos is involved in innovative research projects, including advancements in RNA sequencing technology.

Leadership Changes

Specific details regarding recent leadership changes or appointments within the CTSC are not publicly disclosed.

Competitor Profile

Market Insights and Dynamics

The CTSC operates within a competitive landscape of academic health centers and research institutions focused on clinical and translational research. Key competitors include institutions like the Institute for Translational Sciences at the University of Texas Medical Branch, which also holds a CTSA and engages in similar research activities.

Competitor Analysis

• Institute for Translational Sciences (ITS) at the University of Texas Medical Branch: Established in 2007, ITS is the academic home of UTMB’s CTSA, focusing on advancing translational research for better health and wellness. ITS offers programs in team science, enhancing research, engaging communities, and education, aiming to facilitate translational research as a rigorous discipline.

Strategic Collaborations and Partnerships

The CTSC collaborates with various institutions and community organizations to enhance its research capabilities and community engagement. For instance, the CTSC has partnered with the University of Arizona to expand patient enrollment and engagement in NIH-funded clinical studies through the PC-BRIDGE initiative.

Operational Insights

The CTSC differentiates itself through its comprehensive support for clinical and translational research, including a fully equipped clinical research unit, advanced biomedical informatics tools, and a translational laboratory. Its focus on community engagement and addressing health disparities in rural areas further strengthens its position in the market.